Company news

Nephros, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Nephros and Donastar Announce Strategic Partnership

February 28, 2023

Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call

February 21, 2023

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022

January 10, 2023

Nephros Announces Results for Quarter Ended September 30, 2022

November 1, 2022

Nephros Third Quarter 2022 Financial Results Conference Call

October 18, 2022

Nephros to Present at LD Micro Main Event XV

October 11, 2022

Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022

October 10, 2022

Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation

September 27, 2022

Nephros Appoints Joe Harris to Its Board of Directors

September 7, 2022

Nephros Announces Results for Quarter Ended June 30, 2022

August 9, 2022

Nephros Second Quarter 2022 Financial Results Conference Call

July 26, 2022

Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months

July 5, 2022

Nephros Receives FDA 510(k) Clearance for HDF Assist Module

May 16, 2022

Nephros Announces Results for Quarter Ended March 31, 2022

May 3, 2022

Nephros First Quarter 2022 Financial Results Conference Call

April 26, 2022

Nephros Unveils New Branding and Website

April 25, 2022

Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

March 20, 2022

Nephros to Present at Q1 Virtual Investor Summit

February 27, 2022

Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results

February 22, 2022

Nephros Fourth Quarter 2021 Financial Results Conference Call

February 8, 2022

Nephros Issues 2022 Shareholder Letter

January 12, 2022

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022

January 10, 2022

Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference

November 22, 2021

Nephros to Present at the Q4 Virtual Investor Summit

November 7, 2021

Nephros Announces Results for Quarter Ended September 30, 2021

November 3, 2021

Nephros Announces Third Quarter 2021 Financial Results Conference Call

October 20, 2021

Nephros Announces Preliminary Results for Third Quarter of 2021

October 7, 2021

Nephros to Present at the LD Micro Main Event

October 4, 2021

Nephros to Present at the Virtual MicroCap Leadership Summit

September 14, 2021

Nephros Appoints Wes Lobo to Chief Commercial Officer

August 31, 2021

Nephros Announces Results for Quarter Ended June 30, 2021

August 4, 2021

Nephros Announces Acquisition of GenArraytion, Inc.

July 11, 2021

Nephros CEO Presenting at Access to Giving Virtual Investor Conference

July 8, 2021

Nephros Announces Preliminary Results for Second Quarter of 2021

July 7, 2021

Nephros Announces Results for Quarter Ended March 31, 2021

May 5, 2021

Nephros Announces First Quarter 2021 Financial Results Conference Call

April 25, 2021

Nephros Announces Preliminary Results for First Quarter of 2021

April 4, 2021

Nephros to Present at the Q1 Virtual Investor Summit

March 15, 2021

Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

March 9, 2021

Nephros Reports 2020 Fourth Quarter and Full Year Financial Results

February 28, 2021

Nephros Announces Fourth Quarter and Full Year 2020 Financial Results Conference Call

February 21, 2021

Nephros Hires Wes Lobo as Chief Marketing Officer

February 17, 2021

Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020

January 11, 2021

Nephros Provides Year-End Technology Update, Including HDF Program Status

January 3, 2021

Nephros to Present at Three November Investment Conferences

November 8, 2020

Nephros Appoints Dan D’Agostino as CFO and Reports Third Quarter Financial Results

November 4, 2020

Nephros Announces Third Quarter 2020 Financial Results Conference Call

October 28, 2020

Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock

October 15, 2020

Nephros Announces Release of DialyPath™, a qPCR-based, Real-time, On-site Endotoxin Assay for Dialysis Water

October 12, 2020

Nephros to Present at MicroCap Rodeo Best Ideas Bowl on October 13th at 11: 30 AM ET

October 6, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 9 decks. Every deck is listed under its year.